509 The OPAL Study: A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of Tosedostat (CHR-2797) in Elderly Subjects with Treatment Refractory or Relapsed Acute Myeloid Leukemia

✍ Scribed by Jorge Cortes; Eric Feldman; Karen Yee; Martin Toal; Alison Richardson; Anthony Charman; Nico Flores

• Book ID: 119218762
• Publisher: Elsevier
• Year: 2011
• Tongue: English
• Weight: 130 KB
• Volume: 11
• Category: Article
• ISSN: 2152-2650
• DOI: 10.1016/j.clml.2011.05.021